Spinout Active LTD

Company profile

Magnitude Biosciences Limited

UK company 11579884, incorporated on 20 September 2018.

Home - Magnitude Biosciences

Preclinical Contract Research Organisation (CRO) providing C. elegans commercial lab servicesKeywords: Preclinical testing, preclinical studies, contract research organisation UK, CRO companies in the UK, preclinical CRO Europe, preclinical contract research, research animals

Company number
11579884
Incorporated
20 Sep 2018
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
20 September 2018

Company number 11579884

Verify at Companies House
Legal name
MAGNITUDE BIOSCIENCES LIMITED
Company type
LTD
Region
North East England
Registered address
Unknown
Insolvency history
No

Latest accounts

Financial period: 1 Mar 2024 to 28 Feb 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
21

Company events

Reference milestones and recent Companies House filing stream events.

7 events
27 Aug
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzU0MTI0NTkyMWFkaXF6a2N4

Published 27 Aug 2026 13:48

19 Aug
2026

Legacy

Miscellaneous

RP01SH01 | Transaction MzUzOTExMjgyM2FkaXF6a2N4

Published 19 Aug 2026 13:24

14 Aug
2026

Memorandum Articles

Incorporation

MA | Transaction MzUzNzIxNDAxMWFkaXF6a2N4 | Paper/PDF filed

Published 18 Aug 2026 23:12

14 Aug
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUY3VTNTNURhZGlxemtjeA | Paper/PDF filed

Published 18 Aug 2026 23:11

14 Aug
2026

Capital Variation Of Rights Attached To Shares

Capital

SH10 | Transaction MzUzNzk3ODM2MGFkaXF6a2N4 | Paper/PDF filed

Published 14 Aug 2026 22:49

10 Aug
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUzNzgzNTk4MWFkaXF6a2N4 | Paper/PDF filed

Published 19 Aug 2026 22:55

20 Sep
2018

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Magnitude Biosciences provides a range of research services, specialising in ageing and drug discovery.

Offers services to test compounds for their ability to slow ageing. Customers are from around the world and include academics and industry.

Project impact

Employs approximately 10 FTEs. Attracted a total of £1125k investment from local investors and the Coronavirus Future Fund. Helped our clients raise investment. Clients include large companies such as Lundbeck (Pharma company).

Employs approximately 6 FTEs. Attracted a total of £625k investment from local investors and the Coronavirus Future Fund

Magnitude Biosciences
2018
Magnitude Biosciences
2018
Magnitude Biosciences
2018
MAGNITUDE BIOSCIENCES LIMITED
2018

Public funding

2 awards
First funded
2023
Funded years
2023, 2025
Age at first award
4 years

Projects

2025 Collaborative R&D Lead participant

Acceleration of Drug Discovery through the development of High-Throughput Screening with Advanced Robotics and Machine Learning

1 May 2025 to 30 Apr 2026

Awarded
£206,181
Total cost £294,544

With a globally ageing population, there is an urgent need for drugs to treat or prevent chronic age-related diseases, making faster drug discovery critical. Increasing the number of compounds screened significantly enhances the chances of finding interventions to slow ageing or prevent such diseases. Magnitude Biosciences is a leading contract research o...

2023 Investment Accelerator Lead participant

Innovative automation to find new interventions that slow ageing

1 Apr 2023 to 30 Jun 2025

Awarded
£249,760
Total cost £356,800

Magnitude Biosciences is a contract research organisation based in Sedgefield, County Durham. It is a world leader in providing research services using the tiny nematode worm called _Caenorhabditis elegans (C. elegans)_ and the only one in based in the UK. This worm has physiological similarities to humans and a very short lifespan (2-3 weeks). It has bee...

Product types

Collaborative R&D Investment Accelerator